ASX - By Stock
|
CGB |
Re:
No Seriously - Where's the update?
|
|
clearview9
|
181 |
52K |
1 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
181
|
52K
|
1
|
|
ASX - By Stock
|
JAT |
Re:
Jat 2.0 - 2021 - A New Year
|
|
clearview9
|
942 |
254K |
10 |
11/04/21 |
11/04/21 |
ASX - By Stock
|
942
|
254K
|
10
|
|
ASX - By Stock
|
JAT |
Re:
Really!
|
|
clearview9
|
10 |
5.3K |
10 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
10
|
5.3K
|
10
|
|
ASX - By Stock
|
JAT |
Re:
JAT to make the moolah
|
|
clearview9
|
300 |
87K |
7 |
21/02/21 |
21/02/21 |
ASX - By Stock
|
300
|
87K
|
7
|
|
ASX - By Stock
|
CGB |
Re:
General Discussion Cannabis
|
|
clearview9
|
183 |
66K |
3 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
183
|
66K
|
3
|
|
ASX - By Stock
|
FFG |
Re:
$1 club
|
|
clearview9
|
2.5K |
888K |
8 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.5K
|
888K
|
8
|
|
ASX - By Stock
|
FFG |
Re:
$1 club
|
|
clearview9
|
2.5K |
888K |
11 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
2.5K
|
888K
|
11
|
|
ASX - By Stock
|
FFG |
Re:
$1 club
|
|
clearview9
|
2.5K |
888K |
26 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
2.5K
|
888K
|
26
|
|
ASX - By Stock
|
FFG |
Re:
Ann: Trading Halt
|
|
clearview9
|
76 |
25K |
6 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
76
|
25K
|
6
|
|
ASX - By Stock
|
EVR |
Re:
Lithium
|
|
clearview9
|
70 |
20K |
7 |
28/01/21 |
28/01/21 |
ASX - By Stock
|
70
|
20K
|
7
|
|
Charts
|
PER |
Re:
Chart
|
|
clearview9
|
5.9K |
2.3M |
18 |
18/01/21 |
18/01/21 |
Charts
|
5.9K
|
2.3M
|
18
|
|
ASX - By Stock
|
PER |
Re:
Sarepta gene therapy study missed key target in Duchennes
|
|
clearview9
|
413 |
167K |
9 |
13/01/21 |
13/01/21 |
ASX - By Stock
|
413
|
167K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Dosing
|
|
clearview9
|
49 |
13K |
4 |
09/01/21 |
09/01/21 |
ASX - By Stock
|
49
|
13K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Dosing
|
|
clearview9
|
49 |
13K |
13 |
09/01/21 |
09/01/21 |
ASX - By Stock
|
49
|
13K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Wilsons: 57c price target in 12 months
|
|
clearview9
|
44 |
15K |
3 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
44
|
15K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual Report
|
|
clearview9
|
12 |
3.3K |
6 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
12
|
3.3K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Funds, Sarepta GT, new technologies
|
|
clearview9
|
16 |
5.2K |
8 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
16
|
5.2K
|
8
|
|
ASX - By Stock
|
PER |
Re:
ODD....DESIGNATED!! here we go!
|
|
clearview9
|
25 |
7.3K |
8 |
22/10/20 |
22/10/20 |
ASX - By Stock
|
25
|
7.3K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: ATL1102 shows significant improvement vs external control
|
|
clearview9
|
84 |
23K |
10 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
84
|
23K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Grants RPDD to ATL1102 for the treatment of DMD
|
|
clearview9
|
109 |
29K |
4 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
109
|
29K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: US FDA Grants RPDD to ATL1102 for the treatment of DMD
|
|
clearview9
|
109 |
29K |
13 |
30/09/20 |
30/09/20 |
ASX - By Stock
|
109
|
29K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: ANP to participate at 2020 PPMD Virtual Annual Conference
|
|
clearview9
|
14 |
4.5K |
5 |
16/07/20 |
16/07/20 |
ASX - By Stock
|
14
|
4.5K
|
5
|
|
ASX - By Stock
|
OSP |
Re:
OSP (this coming week)
|
|
clearview9
|
1.3K |
398K |
5 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
1.3K
|
398K
|
5
|
|
Charts
|
PER |
Re:
Chart
|
|
clearview9
|
5.9K |
2.3M |
0 |
19/02/20 |
19/02/20 |
Charts
|
5.9K
|
2.3M
|
0
|
|
ASX - By Stock
|
PER |
Re:
ATL1102 Blockbuster drug in 2020 and a Coy maker.
|
|
clearview9
|
183 |
94K |
2 |
27/12/19 |
27/12/19 |
ASX - By Stock
|
183
|
94K
|
2
|
|
ASX - By Stock
|
PER |
Re:
ATL1102 Blockbuster drug in 2020 and a Coy maker.
|
|
clearview9
|
183 |
94K |
4 |
27/12/19 |
27/12/19 |
ASX - By Stock
|
183
|
94K
|
4
|
|
ASX - By Stock
|
PER |
Re:
next Biotech
|
|
clearview9
|
34 |
17K |
0 |
21/12/19 |
21/12/19 |
ASX - By Stock
|
34
|
17K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Sell side looks thin
|
|
clearview9
|
167 |
67K |
1 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
167
|
67K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Sell side looks thin
|
|
clearview9
|
167 |
67K |
1 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
167
|
67K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Sell side looks thin
|
|
clearview9
|
167 |
67K |
0 |
09/12/19 |
09/12/19 |
ASX - By Stock
|
167
|
67K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Change of Director's Interest Notice - Robert Moses
|
|
clearview9
|
4 |
4.4K |
4 |
04/12/19 |
04/12/19 |
ASX - By Stock
|
4
|
4.4K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Sell side looks thin
|
|
clearview9
|
167 |
67K |
3 |
03/12/19 |
03/12/19 |
ASX - By Stock
|
167
|
67K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Two drugs in phase 2 and one in Phase 2b
|
|
clearview9
|
149 |
66K |
1 |
02/12/19 |
02/12/19 |
ASX - By Stock
|
149
|
66K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Two drugs in phase 2 and one in Phase 2b
|
|
clearview9
|
149 |
66K |
1 |
26/11/19 |
26/11/19 |
ASX - By Stock
|
149
|
66K
|
1
|
|
Charts
|
PER |
Re:
Chart
|
|
clearview9
|
5.9K |
2.3M |
1 |
21/11/19 |
21/11/19 |
Charts
|
5.9K
|
2.3M
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Expiry of Listed Options
|
|
clearview9
|
12 |
7.4K |
4 |
16/11/19 |
16/11/19 |
ASX - By Stock
|
12
|
7.4K
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
clearview9
|
5.9K |
2.3M |
0 |
15/11/19 |
15/11/19 |
Charts
|
5.9K
|
2.3M
|
0
|
|
ASX - By Stock
|
PER |
Re:
Combined Therapies for DMD
|
|
clearview9
|
189 |
92K |
6 |
14/11/19 |
14/11/19 |
ASX - By Stock
|
189
|
92K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Combined Therapies for DMD
|
|
clearview9
|
189 |
92K |
8 |
13/11/19 |
13/11/19 |
ASX - By Stock
|
189
|
92K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Media coverage
|
|
clearview9
|
50 |
27K |
6 |
07/11/19 |
07/11/19 |
ASX - By Stock
|
50
|
27K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Media coverage
|
|
clearview9
|
50 |
27K |
10 |
07/11/19 |
07/11/19 |
ASX - By Stock
|
50
|
27K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Media coverage
|
|
clearview9
|
50 |
27K |
8 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
50
|
27K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Media coverage
|
|
clearview9
|
50 |
27K |
14 |
04/11/19 |
04/11/19 |
ASX - By Stock
|
50
|
27K
|
14
|
|
Charts
|
PER |
Re:
Chart
|
|
clearview9
|
5.9K |
2.3M |
12 |
01/11/19 |
01/11/19 |
Charts
|
5.9K
|
2.3M
|
12
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual Report
|
|
clearview9
|
26 |
12K |
11 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
26
|
12K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual Report
|
|
clearview9
|
26 |
12K |
7 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
26
|
12K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual Report
|
|
clearview9
|
26 |
12K |
13 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
26
|
12K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual Report
|
|
clearview9
|
26 |
12K |
12 |
31/10/19 |
31/10/19 |
ASX - By Stock
|
26
|
12K
|
12
|
|
ASX - By Stock
|
PER |
Re:
Final data read out
|
|
clearview9
|
21 |
12K |
0 |
30/10/19 |
30/10/19 |
ASX - By Stock
|
21
|
12K
|
0
|
|
ASX - By Stock
|
PER |
Final data read out
|
|
clearview9
|
21 |
12K |
11 |
29/10/19 |
29/10/19 |
ASX - By Stock
|
21
|
12K
|
11
|
|